Form 4 for STE Steris
Accepted 2026-06-03 16:40:48 ET · period of report 2026-06-01 · accession 0001628280-26-040438 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-03 16:40 | 2026-06-01 | STE | Madsen Julia | SVP, GM, Life Sciences | F - Tax | $0.00 | -208 | 10.5K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-06-01 | F | D | 208 | $0.00 | 10,502 | D | — | — | (F1) 208 shares were withheld from the 578 restricted shares that vested on June 1, 2026. These 208 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026. (F2) As of June 1, 2026, 3,425 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028. |